Dose down-titration of biological disease-modifying antirheumatic drugs in daily clinical practice: Shared decision-making and patient treatment preferences in Japanese patients with rheumatoid arthritis.

Komiya T, Takase-Minegishi K, Sakurai N, Nagai H, Hamada N, Soejima Y, Sugiyama Y, Tsuchida N, Kunishita Y, Kishimoto D, Kobayashi K, Kamiyama R, Yoshimi R, Kirino Y, Ohno S, Nakajima H. Dose down-titration of biological disease-modifying antirheumatic drugs in daily clinical practice: Shared decision-making and patient treatment preferences in Japanese patients with rheumatoid arthritis. Int J Rheum Dis. 2019 Sep 12.

View in: PubMed